ECG criteria
- The ECG does not diagnose hypomagnesemia: the diagnosis is laboratory-based (serum magnesium), and the tracing merely assesses the risk of arrhythmia
- QT interval: QTc prolongation is possible, but not mandatory and not specific; it is preferable to measure it in lead II or V5–V6 or in another lead where the end of the T wave is most distinct and the interval is longest; corrected for heart rate (Bazett's formula is preferred for tachycardia or bradycardia, Bazett's — for HR around 60–100 bpm); do not include a prominent U wave in the QT measurement
- General thresholds for QTc prolongation (not a specific criterion for hypomagnesemia alone): men ≥ 450 ms, women ≥ 460 ms; the risk of torsades increases when QTc is around 500 ms or more or with a QTc increase of more than 60 ms from baseline
- T wave: flattening or decreased amplitude are possible without a fixed typical localization — a non-specific finding
- ST segment: a slight non-specific depression without localization characteristic of hypomagnesemia is possible; interpret according to standard ischemic criteria and clinical presentation
- U wave: may be enlarged, especially with concomitant hypokalemia (V2–V4); if fused with the T wave, measure QT to the beginning of the U wave and do not interpret the QU interval as QT
- Rhythm: predisposition to ventricular extrasystoles and polymorphic VT/torsades de pointes with concomitant QT prolongation; supraventricular tachyarrhythmias are possible but non-specific
- In patients taking digoxin, hypomagnesemia intensifies the manifestations of digitalis intoxication
What it looks like on ECG
Isolated hypomagnesemia often produces no noticeable ECG changes. No specific and reproducible pattern has been described, so the diagnosis is not made on the ECG — it is a laboratory diagnosis, and the tracing merely serves as a warning and helps assess the risk of arrhythmia.
Possible but non-specific findings:
| Element | Parameter | Note |
|---|---|---|
| QT interval | QTc prolongation | inconsistent, often associated with concomitant K⁺/Ca²⁺ or medications |
| T wave | flattening, decreased amplitude | without characteristic localization |
| ST segment | slight depression | non-specific, not electrolyte-specific |
| U wave | possible enlargement | V2–V4, usually with concomitant hypokalemia |
| Rhythm | ventricular extrasystole, polymorphic VT, torsades de pointes | with concomitant QT prolongation |
When a prominent U wave is present, especially against the background of concomitant hypokalemia, it may merge with the descending limb of the T wave. In this case, it is easy to mistakenly include the U wave in the measured interval and get a false impression of QTc prolongation, although the true QT (to the beginning of the U wave) may be normal or prolonged to a lesser degree. QT should be assessed in multiple leads, choosing the one where the end of the T wave is most clearly visible, and the potassium level should always be taken into account — misinterpreting QU as QT directly affects the assessment of torsades risk and management tactics.
In practice, hypomagnesemia is often combined with hypokalemia and/or hypocalcemia, especially in gastrointestinal losses, diuretic use, alcoholism, and critically ill patients. The actual ECG picture in these cases is composed of a sum of disturbances: prolonged QT, ST depression, and flattened T reflect a mixed electrolyte and/or drug profile, rather than an isolated magnesium effect. The contribution of hypomagnesemia alone cannot be isolated from a single tracing — guidance relies on the clinical situation (diuretics, diarrhea, alcoholism, pancreatitis) and laboratory data.
Mechanism
Magnesium is a cofactor of Na⁺/K⁺-ATPase and a physiological modulator of L-type calcium channels. Its deficiency increases myocardial electrical instability and can promote early and late afterdepolarizations in Purkinje fibers, creating a substrate for triggered activity and polymorphic ventricular tachycardia. A direct and obligatory effect of isolated hypomagnesemia on delayed repolarization and QT prolongation has not been proven — clinically, QT prolongation in hypomagnesemia is usually mediated by concomitant hypokalemia, hypocalcemia, the use of QT-prolonging drugs, or other causes.
A separate significant mechanism is the enhancement of renal potassium loss: a decrease in extracellular magnesium weakens the intracellular inhibition of ROMK channels in the distal nephron, which increases potassium secretion into the tubular lumen. Therefore, hypomagnesemia is often accompanied by hypokalemia that is resistant to potassium supplements without simultaneous magnesium replenishment.
Causes
- Prolonged use of loop and thiazide diuretics
- Chronic alcoholism
- Malabsorption syndromes, chronic diarrhea
- Acute pancreatitis
- Prolonged nutritional deficiency, starvation
- Prolonged proton pump inhibitor therapy
- Nephrotoxic drugs: aminoglycosides, cisplatin, amphotericin B, cyclosporine
- Decompensated diabetes mellitus (osmotic diuresis)
- Renal tubulopathies with magnesium wasting
- Hyperaldosteronism (promotes renal magnesium loss)
- Post-intestinal surgery status, short bowel syndrome
Differential diagnosis
- Hypokalemia: a similar non-specific picture — flattened T, enlarged U, possible ST depression; differentiate by blood potassium, often both disorders coexist
- Long QT syndrome (congenital): QT is persistently prolonged, no relation to electrolytes, does not normalize with magnesium correction
- Use of QT-prolonging drugs: antiarrhythmics, antipsychotics, antibiotics — a medication history is needed
- Hypocalcemia: usually prolongs QT primarily due to the ST segment with a relatively preserved T wave; may accompany hypomagnesemia, differentiation is carried out by laboratory tests
- Myocardial ischemia: assessed by the type and dynamics of ST-T, clinical presentation, serial ECGs, and troponin; diffuse horizontal or downsloping ST depression (often with ST elevation in aVR) can be a sign of high-risk ischemia rather than electrolyte changes, so "diffuseness" by itself does not rule out ACS
Clinical significance and management
Hypomagnesemia is dangerous not in itself, but as a factor provoking life-threatening ventricular arrhythmias, especially with concomitant QT prolongation (congenital or drug-induced) and with concomitant hypokalemia, which is often resistant to potassium therapy without magnesium correction.
Textbook medical management tactics:
- upon detecting QTc prolongation, a flattened T wave, or ST depression on the ECG — check electrolytes: magnesium, potassium, calcium, and review the list of medications being taken
- assess the clinical context: use of diuretics, alcoholism, diarrhea, nutritional status
- with pronounced QTc prolongation and risk factors — continuous rhythm monitoring, discontinuation of precipitating QT-prolonging drugs
- for polymorphic VT/torsades de pointes: in case of hemodynamic instability, immediate unsynchronized defibrillation is indicated, since synchronization of the shock in polymorphic VT is often impossible; simultaneously or immediately thereafter, intravenous magnesium sulfate is administered (regardless of the initial blood magnesium level) and provoking factors are eliminated; potassium correction is carried out in parallel
- when combined with hypokalemia, bear in mind that potassium correction without magnesium may be ineffective
- in recurrent episodes against the background of bradycardia, consider heart rate acceleration (temporary cardiac pacing) according to indications — waiting for laboratory confirmation before acting is unacceptable
- a follow-up ECG after correction of magnesium and other electrolytes assesses treatment efficacy and residual arrhythmic risk, but does not confirm the etiology of the changes without laboratory and clinical data
Common interpretation errors
- Trying to diagnose hypomagnesemia from a single ECG without laboratory confirmation — the signs are non-specific, and normal serum magnesium does not always exclude a deficiency in the body
- Attributing QT prolongation solely to magnesium without checking potassium, calcium, and the list of medications taken
- Including a prominent U wave in the measured QT interval and interpreting QU as QT, which overestimates the assessment of prolongation and the risk of torsades
- Ignoring concomitant hypokalemia, which intensifies the ECG picture and arrhythmogenicity
- Delaying intravenous magnesium administration in torsades de pointes until laboratory results are obtained
- Confusing diffuse ST depression of electrolyte origin with high-risk ischemic depression without evaluating the clinical picture, dynamics, and lead aVR
1. Which of the following is true regarding the ECG in hypomagnesemia?
ECG changes in hypomagnesemia are non-specific and often reflect combined disorders; the diagnosis is confirmed by laboratory tests.
2. What mechanism explains the frequent resistance of hypokalemia to potassium therapy in the presence of concomitant hypomagnesemia?
Magnesium deficiency removes the inhibition of ROMK channels in the distal nephron, enhancing tubular potassium secretion; therefore, without magnesium replenishment, hypokalemia may remain refractory.
3. What is the indicated management for torsades de pointes with hemodynamic instability?
In unstable polymorphic VT/torsades, synchronization of the shock is often impossible, making immediate unsynchronized defibrillation indicated; magnesium sulfate is administered regardless of the baseline magnesium level.
Frequently asked questions
Can hypomagnesemia be diagnosed based on the ECG alone?
No, specific ECG features of hypomagnesemia have not been described, and isolated magnesium deficiency often causes no noticeable changes on the tracing at all. The diagnosis is established by serum magnesium levels; the ECG merely raises suspicion and helps assess arrhythmic risk.
Is hypomagnesemia dangerous for cardiac rhythm?
Yes, especially with concomitant QTc prolongation—it increases the risk of polymorphic ventricular tachycardia, including torsades de pointes, and enhances the manifestations of digitalis toxicity in patients taking digoxin.
How to differentiate ECG changes in hypomagnesemia from hypokalemia?
It is difficult to differentiate on ECG; the pattern is similar and non-specific: flattened T waves, ST depression, and prominent U waves are possible. Differentiation is based on laboratory data, as these disorders frequently coexist.
Why is hypokalemia sometimes refractory to correction without magnesium?
Hypomagnesemia enhances renal potassium wasting by removing the inhibition of ROMK channels in the distal nephron, causing potassium to continue being lost in the urine. In such situations, magnesium repletion is essential for effective correction of hypokalemia.
What QTc level is considered dangerous in hypomagnesemia?
General thresholds for QTc prolongation are $\ge$450 ms in men and $\ge$460 ms in women, adjusted for the correction method (Fridericia's formula is preferred in tachy- or bradycardia). These thresholds do not diagnose hypomagnesemia; the risk of torsades de pointes is especially high when the QTc is approximately 500 ms or more, or when there is an increase in QTc of more than 60 ms from baseline.
ECG Course
Interpretation from basics to myocardial infarction — learn to read any ECG using a systematic algorithm.
- Video lessons and theory for every topic
- Simulator case studies under every lesson
- Unlimited ECG simulator practice
- Study guide: "All ECGs in 25 minutes"
ECG Strip Simulator
ECG, radiology, histology, pathomorphology, pharmacology — thousands of flashcards with detailed explanations.
- Real ECG strips, not textbook drawings
- Instant answers and explanations
- Streaks and progress tracking in your dashboard
Related terms
More in "Electrolytes and Metabolism"
Sources
- Goldberger's Clinical Electrocardiography, 9th ed.
- Surawicz B., Knilans T. Chou's Electrocardiography in Clinical Practice, 6th ed.
- Orlov V.N. Guide to Electrocardiography
Educational material for medical students and physicians. Does not replace clinical guidelines and physical examination; the ECG must always be interpreted in conjunction with the clinical picture.